Financial Trading Blog
Stock of the day 12/08/2015 – Cineworld Group PLC
With Jurassic World, Furious 7 and Avengers: Age of Ultron all breaking into the top 6 grossing films ever, and Minions lurking in the top 40 at just over $900 million, there has been some big hitters in 2015. And these are only the ones in the all-time top 50; Inside Out has grossed over $600 million, Fifty Shades of Grey and Cinderella both over $500 million and San Andreas and Kingsman have each earned more than $400 million apiece.
(Source: IT-Finance.com 12/08/2015)
The draw of these releases has helped push Cineworld to its own record highs this year, with only one notable wobble in the past 8 months. After starting 2015 at £4.17, the stock saw steady gains throughout the first quarter, leading it to trade at £4.49 on the eve of its preliminary full year results in the middle of March. The company then got a further boost with the results themselves, more than doubling its yearly pre-tax profit to £67.3 million despite claiming 2014 ‘was not the easiest year for film’.
This helped carry the stock to £5.03 by the end of May, before a trading update that contained news of a 26.8% climb in revenue caused the stock to jump to a then-record high of £5.23. June, however, brought with it Cineworld’s aforementioned wobble, with the departure of its finance director Philip Bowcock causing the stock to hit a 3 month low of £4.52. Since then, however, the blockbuster success of Jurassic World and Inside Out helped Cineworld announce an 11.2% increase in revenue for the 26 weeks to the start of July, putting the stock on track for its current £5.46 price (IT-Finance.com, 12/08/2015), an all-time high for the company.
Looking ahead to the rest of 2015, and there are still a few mega-movies on their way to help out Cineworld’s top line. In terms of known franchises, the new James Bond film Spectre arrives at the start of November, before The Hunger Games: Mockingjay – Part 2 lands at the end of the month. The potential pièce de résistance then comes on December 18th, as Star Wars Episode VII: The Force Awakens finally hits theatres. Sprinkled amongst these billion dollar (near) guarantees are other potential solid earners like Ridley Scott’s The Martian, Danny Boyle’s Steve Jobs biopic, the latest team-up between Tom Hanks and Steven Spielberg Bridge of Spies, the second Pixar film of the year The Good Dinosaur, and Quentin Tarantino’s The Hateful Eight.
So, in other words, the outlook is looking good for the rest of Cineworld’s 2015. Add into this the company’s push into Eastern Europe, through the £500 million purchase of Cinema City, and analysts are excited about Cineworld. Peel Hunt is expecting, after everything is taken into account, half year earnings of £60 million, whilst Citigroup just started its coverage of the stock with a ‘Buy’ rating and a £7.20 price target. Barclays, meanwhile, claims that cinema admissions will be up 3% for 2015 in total.
Cineworld Group has a consensus rating of ‘Buy’ with an average target price of £5.28.
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.